CD274 and melanoma: Sivan et al. explored the difference in efficacy between two mouse models of melanoma (JAX/TAC) with different intestinal commensal probiotics treated with antibodies targeting PD-L1 (αPD-L1 mAb) and found that Bifidobacterium spp.